Reducing financial hardship from healthcare spending in low- and middle-income countries: a rapid evidence assessment

Closed: The FCDO invited tenders by 22 March 2024 to conduct a rapid evidence assessment of the research literature on the effects of interventions for reducing financial hardship for healthcare in low- and middle-income countries.

• From: Foreign, Commonwealth & Development Office
• Published: 22 February 2024

• Funds: Closed
• Countries: Botswana, Burkina Faso, Cameroon, Congo and Congo (Democratic Republic)
  Show 14 more
  Gabon, Ghana, India, Kenya, Malawi, Mauritius, Namibia, Nigeria, Senegal, South Africa, Tanzania, Uganda, Zambia, and Zimbabwe
• Sector: Health and Livelihoods
• Eligible organisations: Non-governmental organisations (NGOs), UK-based non-profit organisations, Companies, Educational institutions, Individuals and Humanitarian relief organisations
• Value of funding: £10,001 to £100,000

This opportunity closed on 22 March 2024.

Financial protection has been a relatively neglected issue, with much of the focus on coverage of services and medicines. Yet the most recent data is stark: financial protection globally is consistently getting worse.

The Foreign, Commonwealth & Development Office (FCDO) aims to:

• raise the status of financial protection as an issue that needs to be addressed
• contribute to a better understanding of the evidence on the steps that governments and others can take in different contexts to rapidly reduce financial hardship

To deliver a robust rapid evidence assessment, the FCDO seeks a research team that has expertise in:

• undertaking research in the field of health financing in low- and middle-income countries
• conducting rigorous evidence syntheses, including systematic reviews or rapid evidence assessments
• the range of empirical research methods used to evaluate health financing interventions

How to apply

For more information on how to apply, read the invitation the tender instructions and the additional documents.

Email your technical and commercial proposal to [email protected] by 5pm GMT on 22 March 2024. Late bids will not be accepted.

Volume 1: Invitation to tender instructions and evaluation criteria

Volume 2: Terms of reference

Volume 3: Application form

Volume 4: Commercial pro formas

Volume 5: Pro forma contract

Volume 6: Evidence Fund conflict of interest policy

Volume 7: Evidence Fund safeguarding policy

Volume 8: Letter and declaration to accompany tenders

Contact

Evidence Fund Manager: [email protected]

Published 22 February 2024